Sudarshan Pharma Industries Limited (BOM:543828)
India flag India · Delayed Price · Currency is INR
19.41
-1.45 (-6.95%)
At close: Jan 21, 2026

BOM:543828 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
4,8137,3501,784960--
Upgrade
Market Cap Growth
-56.81%312.09%85.79%---
Upgrade
Enterprise Value
6,9838,5732,0071,312--
Upgrade
Last Close Price
20.0030.547.415.56--
Upgrade
PE Ratio
25.3546.0715.5713.64--
Upgrade
PS Ratio
0.811.460.390.21--
Upgrade
PB Ratio
3.425.591.600.95--
Upgrade
P/TBV Ratio
3.585.761.670.96--
Upgrade
P/FCF Ratio
-24.3330.22---
Upgrade
P/OCF Ratio
28.8121.0618.41---
Upgrade
EV/Sales Ratio
1.181.700.430.28--
Upgrade
EV/EBITDA Ratio
15.2421.738.488.62--
Upgrade
EV/EBIT Ratio
15.8222.318.949.17--
Upgrade
EV/FCF Ratio
-59.0328.3734.01---
Upgrade
Debt / Equity Ratio
1.561.300.940.341.031.32
Upgrade
Debt / EBITDA Ratio
4.774.334.432.242.784.08
Upgrade
Debt / FCF Ratio
-5.6517.76--20.26
Upgrade
Asset Turnover
1.431.471.802.493.022.46
Upgrade
Inventory Turnover
3.743.895.277.109.478.69
Upgrade
Quick Ratio
0.540.630.820.790.720.87
Upgrade
Current Ratio
1.191.291.481.681.261.23
Upgrade
Return on Equity (ROE)
14.80%13.12%10.77%10.76%20.06%12.60%
Upgrade
Return on Assets (ROA)
6.67%7.01%5.44%4.83%5.36%5.28%
Upgrade
Return on Invested Capital (ROIC)
10.27%11.00%9.98%11.56%13.43%11.01%
Upgrade
Return on Capital Employed (ROCE)
25.30%26.90%18.30%12.60%29.10%23.80%
Upgrade
Earnings Yield
4.05%2.17%6.42%7.33%--
Upgrade
FCF Yield
-2.46%4.11%3.31%-44.92%--
Upgrade
Dividend Yield
---0.54%--
Upgrade
Payout Ratio
--6.30%---
Upgrade
Buyback Yield / Dilution
-2.62%-1.30%0.83%-66.88%5.63%-
Upgrade
Total Shareholder Return
-2.62%-1.30%0.83%-66.34%5.63%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.